Last €2.70 EUR
Change Today 0.00 / 0.00%
Volume 0.0
EZB On Other Exchanges
Symbol
Exchange
New York
Munich
As of 2:16 AM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Barry W. Weiner

Co-Founder, President, Chief Financial Officer, Principal Accounting Officer, Treasurer and Director, Enzo Biochem Inc.
AgeTotal Calculated CompensationThis person is connected to 4 board members in 1 different organizations across 3 different industries.

See Board Relationships
64$945,778
As of Fiscal Year 2014

Background*

Mr. Barry W. Weiner has been the President of Enzo Biochem Inc. at Enzo Life Sciences, Inc. since November 1996. Mr. Weiner co-founded Enzo Biochem Inc., holding company of Enzo Clinical Labs, Inc. and has been its President since November 1996. Mr. Weiner serves as the Chief Financial Officer and Principal Accounting Officer of Enzo Biochem Inc. and has been its Treasurer since November 25, 2009. He served as Executive Vice President of Enzo Biochem Inc., from September ...

Read Full Background

Corporate Headquarters*

527 Madison Avenue
New York, New York 10022

United States

Phone: 212-583-0100
Fax: --

Board Members Memberships*

1977-Present
Co-Founder, President, Chief Financial Officer, Principal Accounting Officer, Treasurer and Director

Education*

MBA
Boston University
Bachelor's Degree
New York University
BS
New York University

Other Affiliations*

Annual Compensation*

Salary$492,708
Total Annual Compensation$492,708

Stock Options*

All Other Compensation$153,233
Exercisable Options50,000
Unexercisable Options64,107
Total Number of Options114,107

Total Compensation*

Total Annual Cash Compensation$910,941
Total Short Term Compensation$492,708
Other Long Term Compensation$153,233
Total Calculated Compensation$945,778
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EZB:GR €2.70 EUR 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Raymond C. Kubacki Jr.Chairman, Chief Executive Officer and President
Psychemedics Corp.
$500.4K
Douglas M. VanOort Executive Chairman and Chief Executive Officer
Neogenomics Inc.
$557.0K
Thomas A. Bologna Chairman and Chief Executive Officer
Response Genetics, Inc
$900.3K
Ivan D. Trifunovich Ph.D.Chairman of The Board, Chief Executive Officer and President
WaferGen Bio-systems, Inc.
$720.0K
R. Bradley Gray Chief Executive Officer, President and Director
NanoString Technologies, Inc.
$384.2K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ENZO BIOCHEM INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.